What is the science driving CVD and T2DM?
Expert Meeting on CVD & T2DM10' education - Mar. 22, 2018 - Wouter Jukema, Stephan Jacob, Ulf Landmesser
Video navigation menu
- Is diabetes truly a state of enhanced CV risk? 0:43
- What is the impact of glucose-lowering in current diabetes management? 2:45
- Side-effects of treatment may have offset the benefits of better glycemic control in the past 3:43
- Which mechanisms, beyond glucose lowering, may contribute to the achieved CV risk reduction 6:10
- Preventing weight gain and reducing obesity should be part of T2DM management 8:02
- Concluding remarks 9:03
This video was recorded during a two-day expert meeting among cardiologists and endocrinologists/internists, focussing on the topic of 'Exploring the role of GLP-1 RA in the management of CVD & T2DM'. This video reflects the discussion in the first of five sessions.
- Prof. Wouter Jukema - cardiologist, Leiden University Medical Center, Leiden, The Netherlands
- Prof. Stephan Jacob - endocrinologist, Praxis für Prävention und Therapie, Villingen-Schwenningen, Germany
- Prof. Ulf Landmesser - cardiologist, Charité-Universitätsmedizin Berlin, Germany
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Funding for the Expert Meeting was provided by an unrestricted educational grant from Novo Nordisk. The sponsor did not attend and influence the meeting or the video recording.